Related references
Note: Only part of the references are listed.Glioblastoma: Clinical characteristics, prognostic factors and survival in 492 patients
Andreas M. Stark et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2012)
Comparison of F-18 FDG and C-11 Methionine PET/CT for the Evaluation of Recurrent Primary Brain Tumors
Madhavi Tripathi et al.
CLINICAL NUCLEAR MEDICINE (2012)
Biomarkers Classification and Therapeutic Decision-Making for Malignant Gliomas
Adriana Olar et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
PET/MRI in infectious and inflammatory diseases: will it be a useful improvement?
Andor W. J. M. Glaudemans et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Bevacizumab for the treatment of high-grade glioma
Mustafa Khasraw et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Clinical Value of [11C]Methionine PET for Stereotactic Radiation Therapy With Intensity Modulated Radiation Therapy to Metastatic Brain Tumors
Kazuhiro Miwa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions
Shozo Okamoto et al.
ANNALS OF NUCLEAR MEDICINE (2011)
French Brain Tumor DataBase: 5-Year Histological Results on 25 756 Cases
Valerie Rigau et al.
BRAIN PATHOLOGY (2011)
Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?
Christian Hartmann et al.
CLINICAL CANCER RESEARCH (2011)
BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
Cynthia Hawkins et al.
CLINICAL CANCER RESEARCH (2011)
Comparison of C-11 Methionine and C-11 Choline for PET Imaging of Brain Metastases A Prospective Pilot Study
Christof Rottenburger et al.
CLINICAL NUCLEAR MEDICINE (2011)
Anaplastic gliomas: an emerging entity
Wolfgang Wick
EUROPEAN JOURNAL OF CANCER (2011)
Radionuclide imaging of bone marrow disorders
Ali Agool et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
AN INTERINDIVIDUAL COMPARISON OF O-(2-[18F]FLUOROETHYL)-L-TYROSINE (FET)- AND L-[METHYL-11C]METHIONINE (MET)-PET IN PATIENTS WITH BRAIN GLIOMAS AND METASTASES
Anca-Ligia Grosu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Grading of Gliomas: The Road From Eminence to Evidence
Johan M. Kros
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography
Natsuki Shinozaki et al.
JOURNAL OF NEUROSURGERY (2011)
Examination of 11C-Methionine Metabolism by the Standardized Uptake Value in the Normal Brain of Children
Takashi Nagata et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
M. J. van den Bent et al.
LANCET ONCOLOGY (2011)
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response
Walter Taal et al.
NEURO-ONCOLOGY (2011)
Therapeutic options for recurrent malignant glioma
Maximilian Niyazi et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: Assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI
Yong Hwy Kim et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
E. C. Dijkers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Management of Low-Grade Glioma
Nader Pouratian et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2010)
Clinical impact of C-11-methionine PET on expected management of patients with brain neoplasm
Tomohiko Yamane et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
Shannon E. Fogh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
[(11)C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors
Norbert Galldiks et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Correlation of l-methyl-11C-methionine (MET) uptake with l-type amino acid transporter 1 in human gliomas
Shuichi Okubo et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Substitution of 11C-methionine PET by perfusion MRI during the follow-up of treated high-grade gliomas: Preliminary results in clinical practice
V. Dandois et al.
JOURNAL OF NEURORADIOLOGY (2010)
Hybrid PET/MRI of Intracranial Masses: Initial Experiences and Comparison to PET/CT
Andreas Boss et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
Frederic G. Dhermain et al.
LANCET NEUROLOGY (2010)
Exploration of symptoms clusters within cancer patients with brain metastases using the Spitzer Quality of Life Index
Amanda Hird et al.
SUPPORTIVE CARE IN CANCER (2010)
Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2009)
Pseudoprogression and pseudoresponse in the treatment of gliomas
Dieta Brandsma et al.
CURRENT OPINION IN NEUROLOGY (2009)
TARGET DEFINITION BY C11-METHIONINE-PET FOR THE RADIOTHERAPY OF BRAIN METASTASES
Masayuki Matsuo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
ASSOCIATION OF 11C-METHIONINE PET UPTAKE WITH SITE OF FAILURE AFTER CONCURRENT TEMOZOLOMIDE AND RADIATION FOR PRIMARY GLIOBLASTOMA MULTIFORME
Irwin H. Lee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Methyl-L-C-11-Methionine PET as a Diagnostic Marker for Malignant Progression in Patients with Glioma
Roland T. Ullrich et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up
Linda Douw et al.
LANCET NEUROLOGY (2009)
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
Eric L. Chang et al.
LANCET ONCOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Analysis of 11C-methionine Uptake in Low-Grade Gliomas and Correlation with Proliferative Activity
T. Kato et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography
T. Kato et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Gliomas With 1p/19q Codeletion: a.k.a. Oligodendroglioma
Gregory Cairncross et al.
CANCER JOURNAL (2008)
Treating Recurrent Cases of Squamous Cell Carcinoma with Radiotherapy
Jennifer Jing-Wen Wong et al.
Current Oncology (2008)
Proliferation Markers for the Differential Diagnosis of Tumor and Inflammation
Aren Waarde et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma
Tetsuhiro Hatakeyama et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas
Justin S. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy
Yuzo Terakawa et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Dieto Brandsma et al.
LANCET ONCOLOGY (2008)
C-11-acetate PET in the evaluation of brain glioma: Comparison with C-11-methionine and F-18-FDG-PET
Y. Yamamoto et al.
MOLECULAR IMAGING AND BIOLOGY (2008)
Glioma extent of resection and its impact on patient outcome
Nader Sanai et al.
NEUROSURGERY (2008)
Three-dimensional Gaussian model to define brain metastasis limits on 11C-methionine PET
Bich-Ngoc-Thanh Tang et al.
RADIOTHERAPY AND ONCOLOGY (2008)
FDG, MET or CHO?: The quest for the optimal PET tracer for glioma imaging continues
Balazs Gulyas et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Adding C-11-methionine PET to the EORTC prognostic factors in grade 2 gliomas
A. Smits et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
C-11-L-methionine positron emission tomography in the clinical management of cerebral gliomas
Tarun Singhal et al.
MOLECULAR IMAGING AND BIOLOGY (2008)
Non-invasive grading of brain tumours using dynamic amino acid PET imaging:: does it work for 11C-Methionine?
Gerard Moulin-Romsee et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Evaluation of primary brain tumors using 11C-methionine PET with reference to a normal methionine uptake map
David J. Coope et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
[11C] Methionine and [18F] Fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme
Christian Poetzi et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Radiotherapy for glioblastoma in the elderly
Florence Keime-Guibert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
11C-methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas
H. Gumprecht et al.
ZENTRALBLATT FUR NEUROCHIRURGIE (2007)
Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life
Raffaele Addeo et al.
BMC CANCER (2007)
Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: Preliminary results
Niloufar Sadeghi et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2006)
Differentiation of tumour and inflammation:: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells
Barbara Stoeber et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
Gregory Cairncross et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L-tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat
Nicolas Spaeth et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures
B Pirotte et al.
JOURNAL OF NEUROSURGERY (2006)
Brain metastases: epidemiology and pathophysiology
IT Gavrilovic et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults:: the EORTC 22845 randomised trial
MJ van den Bent et al.
LANCET (2005)
Usefulness Of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma
T Nariai et al.
JOURNAL OF NEUROSURGERY (2005)
Radiosurgery with or without whole-brain radiotherapy for brain Metastases - The patients' perspective regarding complications
D Kondziolka et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2005)
Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas
D Ribom et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Effectiveness of whole brain radiotherapy in the treatment of brain metastases: a systematic review
NJ Pease et al.
PALLIATIVE MEDICINE (2005)
Direct comparison of F-18-FDG and C-11-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value
K Van Laere et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
C-11-methionine PET as a prognostic marker in patients with glioma: comparison with F-18-FDG PET
S Kim et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy
AL Grosu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies
B Pirotte et al.
JOURNAL OF NEUROSURGERY (2004)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery - In malignant glioma
N Tsuyuguchi et al.
ANNALS OF NUCLEAR MEDICINE (2004)
Delineation of brain tumor extent with [11C]L-methionine positron emission tomography:: Local comparison with stereotactic histopathology
LW Kracht et al.
CLINICAL CANCER RESEARCH (2004)
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
DW Andrews et al.
LANCET (2004)
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial
W Roa et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Brain tumour imaging with PET:: a comparison between [18F]fluorodopa and [11C]methionine
A Becherer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Supportive care management of brain metastases: What is known and what we need to know - Conference Proceedings of the National Cancer Institute of Canada (NCIC) Workshop on Symptom Control in Radiation Oncology
MN Tsao et al.
CLINICAL ONCOLOGY (2003)
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group study 26971
MJ van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Methyl-[11C]-L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma
LW Kracht et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
N Tsuyuguchi et al.
JOURNAL OF NEUROSURGERY (2003)
Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls
JJ McAleese et al.
RADIOTHERAPY AND ONCOLOGY (2003)
Continuous growth of mean tumor diameter in a subset of grade II gliomas
E Mandonnet et al.
ANNALS OF NEUROLOGY (2003)
Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma
LJ Schouten et al.
CANCER (2002)
Prospective Randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study
E Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET
JK Chung et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Cranial neuronavigation with direct integration of C-11 methionine positron emission tomography (PET) data - Results of a pilot study in 32 surgical cases
V Braun et al.
ACTA NEUROCHIRURGICA (2002)
Symptom response after palliative radiotherapy for patients with brain metastases
A Bezjak et al.
EUROPEAN JOURNAL OF CANCER (2002)
From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology
K Kubota
ANNALS OF NUCLEAR MEDICINE (2001)
Combined magnetic resonance imaging- and positron emission tomography-guided stereotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients
N Massager et al.
JOURNAL OF NEUROSURGERY (2000)
Radiotherapy treatment planning and long-term follow-up with [11C]methionine pet in patients with low-grade astrocytoma
J Nuutinen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours:: initial results of a comparative study
WA Weber et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Share Paper
